Mylan (MYL) Unit Launches Generic Seroquel Tabs (AZN)

Mylan Inc. (Nasdaq: MYL) reports that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Quetiapine Fumarate Tablets, 25 mg. This product is the generic version of AstraZeneca's (NYSE: AZN) Seroquel, which is an atypical antipsychotic medication indicated for the treatment of schizophrenia, and for the treatment of acute manic episodes associated with bipolar disorder.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
• Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
• Nuvectis Pharma (NVCT) files $200M mixed shelf